Moshe Arkin

CIK 1321178 · Vice Chairman · last filed 2026-03-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.97M

Companies

5

Total Filings

87

Lifetime Open-Market Net

-$263.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ODYS Director 2,624,838 $3.67 $9.63M $0 1 2026-03-27
HOWL 10%+ Owner 1,235,917 $0.38 $470.9K $19.20M 1 2021-05-04
KROS 10%+ Owner 1,725,565 $10.15 $17.51M $5.76M 1 2020-04-13
PRGO Director 5,036,958 $10.99 $55.36M -$285.73M 80 2011-09-02
Orexigen Therapeutics, Inc. (OREX) Delisted 4,609,643 -$2.47M 1 2010-08-16

Recent Filings · Page 3 of 9

87 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2010-08-23 PRGO Grant (A) +11,406 $0 EDGAR
2010-08-16 Orexigen Therapeutics, Inc. (OREX) Delisted Sell (S) −520,000 -$2.47M EDGAR
2010-07-29 Buy (P) +2,889,672 $22.88M
2010-07-29 Buy (P) +324,048 $2.34M
2009-12-07 PRGO Exer (M) +55,000 $819.6K EDGAR
2009-11-12 PRGO Grant (A) +1,514 $0 EDGAR
2009-10-07 PRGO Sell (S) −27,516 -$935.8K EDGAR
2009-10-02 PRGO Sell (S) −234,890 -$8.02M EDGAR
2009-10-01 PRGO Sell (S) −36,736 -$1.25M EDGAR
2009-08-27 PRGO Grant (A) +5,680 $0 EDGAR
Showing 2130 of 87
Page 3 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.